Reliq Health Technologies - CEO Dr. Lisa Crossley
CEO Dr. Lisa Crossley
Source: Reliq Health Technologies
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Reliq Health Technologies (RHT) has signed new contracts with four Pain Management clinics in California
  • These clinics are expected to add at least 2,000 new patients to its platform at an average revenue of $50 per patient per month
  • Onboarding is expected to begin in August
  • Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring
  • Reliq Health Technologies Inc. (RHT) opened trading at C$0.58 per share

Reliq Health Technologies (RHT) has signed new contracts with four Pain Management clinics in California.

These contracts will add at least 2,000 new patients to Reliq’s platform.

“We are very excited to be welcoming four Pain Management clinics in California as new clients,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc.

“There are over 5 million Medicare recipients who suffer from life-altering chronic pain. Remote monitoring of symptoms and management of pain medications and underlying chronic conditions can dramatically improve quality of life for chronic pain patients. Proactive management of chronic pain can also reduce the risk of addiction to pain medication and the resulting costs to the healthcare system. The new iUGO Care Pain Management module allows clinicians to provide critical support and services to patients living with chronic pain and further expands Reliq’s addressable patient population to over 60 Million eligible patients. These four clinics are expected to add over 2,000 patients to our platform in the next nine months at an average revenue of $50 per patient per month at 75% gross margin. Onboarding of these patients is expected to begin next month.”

Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Reliq Health Technologies Inc. (RHT) opened trading at C$0.58 per share.


More From The Market Herald
Emerald Health Therapeutics Inc. - Director & Chairman, Jim Heppell.

" Emerald Health (CSE:EMH) shareholders approve merger

Emerald Health Therapeutics (EMH), has received shareholders’ approval for the proposed plan of arrangement with Skye Bioscience Inc.
Mydecine Innovations Group - CEO, Josh Bartch.

" Mydecine (NEO:MYCO) raises $244K and shifts management team

Mydecine Innovations Group (MYCO) has signed a common share subscription agreement with a third-party investor for proceeds up to $244,99.50.
PharmaDrug - CEO, Daniel Cohen

" PharmaDrug (CSE:PHRX) completes milestone to support cGMP production of PD-001

PharmaDrug (PHRX) has laid the groundwork to support cGMP production of cepharanthine-2HCL for use in the drug product production of PD-001.

" Hemostemix (TSXV:HEM) announces $1.5M non-brokered private placement

Hemostemix (HEM) has announced a non-brokered private placement of up to 5 million units for gross proceeds of up to $1.5 million.